brow ptosis brow ptosis, thread lifting
Conditions
Interventions
Each participant will undergo eyebrow lifting using multiple bidirectional Newton cog polydioxanone (PDO) threads in a single treatment session
Experimental Device
Sponsors
Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand
Eligibility
Sex/Gender
All
Age
25 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Participants aged 25 to 60 years, including both males and females. 2. Participants with brow ptosis who do not have indications for surgical intervention, or participants with normal brow position who wish to enhance brow elevation for cosmetic purposes.
Exclusion criteria
Exclusion criteria: 1. Pregnant or breastfeeding women. 2. Participants with underlying medical conditions, including platelet disorders, coagulation abnormalities, anemia, liver disease, malignancy, or autoimmune disorders. 3. Participants who smoke or have a history of excessive alcohol consumption. 4. Participants with dermatitis, open wounds, or skin infections in the eyebrow area. 5. Participants with a history of allergy to local anesthetics. 6. Participants with a history of hormonal therapy, injectable or oral contraceptives, or regular use of NSAIDs. 7. Participants who have received facial filler injections or botulinum toxin within 6 months prior to study enrollment. 8. Participants who have undergone facial lifting or tightening procedures within 6 months prior to study enrollment. 9. Participants with a history of keloid or hypertrophic scarring. 10. Participants with a psychiatric disorder diagnosed by a psychiatrist. 11. Participants who do not consent to facial photography for treatment evaluation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Eye brow height baseline, immediate after treatment, 1 week, 1 month, 3 months, and 6 months following treatment Vectra | — |
Secondary
| Measure | Time frame |
|---|---|
| Participants improvement scale immediate after treatment, 1 week, 1 month, 3 months, and 6 months following treatment Quartile scale,Safety immediate after treatment, 1 week, 1 month, 3 months, and 6 months following treatment Adverse event,Pain score at treatment Visual analog scale | — |
Countries
Thailand
Contacts
Public ContactThanya Techapichetvanich
Department of Dermatology, Faculty of Medicine Siriraj hospital, Mahidol university
Outcome results
None listed